OTCMKTS:SNYNF - Roche Stock Price, News & Analysis

$84.54
+0.64 (+0.76 %)
(As of 08/22/2019 12:47 PM ET)
Today's Range
$84.54
Now: $84.54
$84.85
50-Day Range N/A
52-Week Range
$80.80
Now: $84.54
$91.46
Volume5,200 shs
Average Volume11,216 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. The company has an alliance with Verily Life Sciences LLC. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SNYNF
CUSIPN/A
CIKN/A
Phone33 1 53 77 40 00

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees100,000
Next Earnings DateN/A
OptionableNot Optionable

Receive SNYNF News and Ratings via Email

Sign-up to receive the latest news and ratings for SNYNF and its competitors with MarketBeat's FREE daily newsletter.


Roche (OTCMKTS:SNYNF) Frequently Asked Questions

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "SNYNF."

What price target have analysts set for SNYNF?

1 equities research analysts have issued 12 month target prices for Roche's shares. Their predictions range from $95.00 to $95.00. On average, they expect Roche's stock price to reach $95.00 in the next year. This suggests a possible upside of 12.4% from the stock's current price. View Analyst Price Targets for Roche.

What is the consensus analysts' recommendation for Roche?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Roche.

Has Roche been receiving favorable news coverage?

Headlines about SNYNF stock have trended positive on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Roche earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View News Stories for Roche.

Who are some of Roche's key competitors?

Who are Roche's key executives?

Roche's management team includes the folowing people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 63)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 54)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

How do I buy shares of Roche?

Shares of SNYNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Roche's stock price today?

One share of SNYNF stock can currently be purchased for approximately $84.54.

What is Roche's official website?

The official website for Roche is http://www.sanofi.com/.

How can I contact Roche?

The company can be reached via phone at 33 1 53 77 40 00.


MarketBeat Community Rating for Roche (OTCMKTS SNYNF)

Community Ranking:  4.2 out of 5 (star star star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  1 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Roche and other stocks. Vote "Outperform" if you believe SNYNF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNYNF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Featured Article: Hold Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel